Akebia Could Face Long, Costly Effort To Overcome Vadadustat CRL

Company Pins Hopes On Partner Otsuka’s EMA Application

 
• By Alaric DeArment
Akebia received a complete response letter for its CKD anemia drug, vadadustat • Source: Alamy

More from New Products

More from Scrip